Success Metrics

Clinical Success Rate
100.0%

Based on 15 completed trials

Completion Rate
100%(15/15)
Active Trials
2(11%)
Results Posted
60%(9 trials)

Phase Distribution

Ph not_applicable
5
26%
Ph phase_2
1
5%
Ph phase_1
1
5%
Ph phase_3
5
26%
Ph phase_4
3
16%

Phase Distribution

1

Early Stage

1

Mid Stage

8

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
1(6.7%)
Phase 2Efficacy & side effects
1(6.7%)
Phase 3Large-scale testing
5(33.3%)
Phase 4Post-market surveillance
3(20.0%)
N/ANon-phased studies
5(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

15 of 15 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

19

all time

Status Distribution
Active(2)
Completed(15)
Other(2)

Detailed Status

Completed15
unknown2
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
19
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (6.7%)
Phase 21 (6.7%)
Phase 35 (33.3%)
Phase 43 (20.0%)
N/A5 (33.3%)

Trials by Status

unknown211%
completed1579%
recruiting211%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT05385952Not Applicable

GATT-Patch Versus TachoSil in Liver Surgery

Completed
NCT06664775Phase 3

A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery

Recruiting
NCT04660721Phase 1

A Study Evaluating the Safety and Preliminary Efficacy of sFilm-FS in Controlling Parenchymal Bleeding During Elective Hepatic Surgery

Completed
NCT06124209Phase 4

Use of Fibrin Sealant Patch for Vein Anastomosis During Deceased Donor Liver Transplantation- Randomized Clinical Trial

Recruiting
NCT05986201

Assessment of Long-term Effects of Tachosil

Completed
NCT04065880Not Applicable

Neoveil® Versus TachoSil® for the Treatment of Pulmonary Air Leaks Following Lung Operation

Completed
NCT05717335

Observational Pilot Study With TachoSil as a Ventricular Sealant

Completed
NCT04428463Not Applicable

Repair of Tympanic Membrane Perforation Using Tachosil Under Local Anesthesia

Unknown
NCT03450265Not Applicable

Hemopatch Compared to TachoSil in Postoperative Air Leak Duration After Pulmonary Resection

Completed
NCT02685007

RollOut -Pre-Rolled TachoSil in Laparoscopic Utilisation. A Non-Interventional Study

Completed
NCT02284256Phase 3

A Safety and Efficacy Study Comparing Fibrocaps and Tachosil in Hepatic Surgery

Completed
NCT02629510Phase 4

The Efficacy of Tachosil® for Prevention of Hemorrhage After Loop Electrosurgical Excisional Procedure (LEEP)

Unknown
NCT01500135Phase 3

Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment of Needle Hole Bleeding in Vascular Surgery

Completed
NCT01920958

Use of Tachosil® for Lymph Sealing During Surgery

Completed
NCT01192022Phase 3

TachoSil® Versus Surgicel® Original for the Secondary Treatment of Local Bleeding in Adult and Pediatric Patients Undergoing Hepatic Resection Surgery

Completed
NCT00918619Phase 4

Efficacy and Safety of Sangustop® as Haemostatic Agent Versus a Carrier-Bound Fibrin Sealant During Liver Resection

Completed
NCT01355627Phase 3

TASALL - TachoSil® Against Liquor Leak

Completed
NCT01639833Not Applicable

A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery

Completed
NCT00713661Phase 2

Evaluation of TachoSil® Application on a Colorectal Anastomosis (TC-029-IM)

Completed

All 19 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
19